OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 83 filers reported holding OVID THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $25 | -100.0% | 13,392 | -31.3% | 0.00% | -100.0% |
| Q3 2021 | $65,000 | -69.2% | 19,491 | -63.9% | 0.00% | -50.0% |
| Q2 2021 | $211,000 | +151.2% | 53,935 | +270.4% | 0.00% | 0.0% |
| Q3 2020 | $84,000 | -44.4% | 14,561 | -71.2% | 0.00% | -75.0% |
| Q1 2020 | $151,000 | -75.4% | 50,557 | -65.8% | 0.01% | -33.3% |
| Q4 2019 | $613,000 | – | 147,740 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
| BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
| EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
| GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
| Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
| CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
| Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
| DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
| Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
| XTX Topco Ltd | 50,569 | $198,000 | 0.07% |